Large granular lymphocytic leukemia. Current diagnostic and therapeutic approaches and novel treatment options

References

• Loughran TP Jr, Kadin ME, Starkebaum G, et al. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med. 1985 Feb;102(2):169–175.
   PubMed Web of Science ®Google Scholar
• Chan WC, Foucar K, Morice WG, et al. T-cell large granular lymphocytic leukaemia. In: Swerdlow CE, Harris NL, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 272–273.
   Google Scholar
• Villamor N, Morice WG, Chan WC, et al. Chronic lymphoproliferative disorders of NK cells. In: Swerdlow CE, Nl H, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 274–275.
   Google Scholar
• Bareau B, Rey J, Hamidou M, et al. Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases. Haematologica. 2010 Sep;95(9):1534–1541.
   PubMed Web of Science ®Google Scholar
• Dhodapkar MV, Li CY, Lust JA, et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood. 1994 Sep 1;84(5):1620–1627.
   PubMed Web of Science ®Google Scholar
• Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1–14.
   PubMed Web of Science ®Google Scholar
• Semenzato G, Zambello R, Starkebaum G, et al. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood. 1997 Jan 1;89(1):256–260.
   PubMed Web of Science ®Google Scholar
• Watters RJ, Liu X, Loughran TP Jr. T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias. Leuk Lymphoma. 2011 Dec;52(12):2217–2225.
   PubMed Web of Science ®Google Scholar
• Starkebaum G, Loughran TP Jr, Gaur LK, et al. Immunogenetic similarities between patients with Felty’s syndrome and those with clonal expansion of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum. 1997;40:624–626.
   PubMed Web of Science ®Google Scholar
• Lamy T, Loughran TP Jr. How I treat LGL leukemia. Blood. 2011 10;117(10):2764–2774.
   PubMed Web of Science ®Google Scholar
• Viny AD, Maciejewski JP. High rate of both hematopoietic and solid tumors associated with large granular lymphocyte leukemia. Leuk Lymphoma. 2015 Feb;56(2):503–504.
   PubMed Web of Science ®Google Scholar
• Qiu ZY, Xu W, Li JY. Large granular lymphocytosis during dasatinib therapy. Cancer Biol Ther. 2014;15(3):247–255.
   PubMed Web of Science ®Google Scholar
• Poullot E, Zambello R, Leblanc F, et al. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients. Ann Oncol. 2014 Oct;25(10):2030–2035.
   PubMed Web of Science ®Google Scholar
• Morice WG, Kurtin PJ, Leibson PJ, et al. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol. 2003 Mar;120(6):1026–1036.
   PubMed Web of Science ®Google Scholar
• Morice WG, Jevremovic D, Hanson CA. The expression of the novel cytotoxic protein granzyme M by large granular lymphocytic leukaemias of both T-cell and NK-cell lineage: an unexpected finding with implications regarding the pathobiology of these disorders. Br J Haematol. 2007 May;137(3):237–239.
   PubMed Web of Science ®Google Scholar
• Osuji N, Beiske K, Randen U, et al. Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia. Histopathology. 2007 Apr;50(5):547–554.
   PubMed Web of Science ®Google Scholar
• Morice WG, Kimlinger T, Katzmann JA, et al. Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques. Am J Clin Pathol. 2004 Mar;121(3):373–383.
   PubMed Web of Science ®Google Scholar
• Clemente MJ, Wlodarski MW, Makishima H, et al. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood. 2011 Oct 20;118(16):4384–4393.
   PubMed Web of Science ®Google Scholar
• Yang J, Epling-Burnette PK, Painter JS, et al. Antigen activation and impaired Fas-induced death-inducing signalling complex formation in T-large granular lymphocyte leukemia. Blood. 2008;111:1610–1616.
   PubMed Web of Science ®Google Scholar
• Shah MV, Zhang R, Irby R, et al. Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood. 2008;112:770–781.
   PubMed Web of Science ®Google Scholar
• Epling-Burnette PK, Loughran TP Jr. Survival signals in leukemic large granular lymphocytes. Semin Hematol. 2003;40:213–220.
   PubMed Web of Science ®Google Scholar
• Koskela HL, Eldfors S, Ellonen P, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med. 2012 May 17;366(20):1905–1913.
   PubMed Web of Science ®Google Scholar
• Jerez A, Clemente MJ, Makishima H, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012 Oct 11;120(15):3048–3057.
   PubMed Web of Science ®Google Scholar
• Rajala HL, Eldfors S, Kuusanmäki H, et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood. 2013 May 30;121(22):4541–4550.
   PubMed Web of Science ®Google Scholar
• Rajala HL, Mustjoki S. STAT5b in LGL leukemia–a novel therapeutic target? Oncotarget. 2013 Jun;4(6):808–809.
   PubMed Web of Science ®Google Scholar
• Matutes E, Wotherspoon AC, Parker NE, et al. Transformation of T-cell large granular lymphocyte leukemia into a high-grade large T-cell lymphoma. Br J Haematol. 2001;115:801–806.
   PubMed Web of Science ®Google Scholar
• Loughran TP Jr, Kidd PG, Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood. 1994;84:2164–2170.
   PubMed Web of Science ®Google Scholar
• Loughran TP Jr, Zickl L, Olson TL, et al. Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998). Leukemia. 2015 Apr;29(4):886–894.
   PubMed Web of Science ®Google Scholar
• Moignet A, Hasanali Z, Zambello R, et al. Cyclophosphamide as a first-line therapy in LGL leukemia. Leukemia. 2014;28(5):1134–1136.
   PubMed Web of Science ®Google Scholar
• Tsirigotis P, Venetis E, Kapsimali V, et al. 2-deoxycoformycin in the treatment of T-large granular lymphocyte leukemia. Leuk Res. 2003;27:865–867.
   PubMed Web of Science ®Google Scholar
• Fortune AF, Kelly K, Sargent J, et al. Large granular lymphocyte leukemia: natural history and response to treatment. Leuk Lymphoma. 2010;51:839–845.
   PubMed Web of Science ®Google Scholar
• Mercieca J, Matutes E, Dearden C, et al. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol. 1994 Dec;12(12):2588–2593.
   PubMed Web of Science ®Google Scholar
• Sternberg A, Eagleton H, Pillai N, et al. Neutropenia and anaemia associated with T-cell large granular lymphocyte leukemia responds to fludarabine with minimal toxicity. Br J Haematol. 2003;120:699–701.
   PubMed Web of Science ®Google Scholar
• Tse E, Chan JC, Pang A, et al. Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia. Leukemia. 2007;21:2225–2226.
   PubMed Web of Science ®Google Scholar
• Ma SY, Au WY, Chim CS, et al. Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients. Br J Haematol. 2004 Mar;124(6):754–761.
   PubMed Web of Science ®Google Scholar
• Osuji N, Del Giudice I, Matutes E, et al. CD52 expression in T-cell large granular lymphocyte leukemia–implications for treatment with alemtuzumab. Leuk Lymphoma. 2005;46:723–727.
   PubMed Web of Science ®Google Scholar
• Dumitriu B, Ito S, Feng X, et al. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. Lancet Haematol. 2016 Jan;3(1):e22–9.
   PubMed Web of Science ®Google Scholar
• O´Mahony D, Morris JC, Stetler-Stevenson M, et al. EBV related lymphoprolipherative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies. Clin Cancer Res. 2009;15:2514–2522.
   PubMed Web of Science ®Google Scholar
• Hodge DL, Yang J, Buschman MD, et al. Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias. Cancer Res. 2009 May 1;69(9):3986–3994.
   PubMed Web of Science ®Google Scholar
• Morris JC, Janik JE, White JD, et al. Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proc Natl Acad Sci USA. 2006 Jan 10;103(2):401–406.
   PubMed Web of Science ®Google Scholar
• Epling-Burnette PK, Sokol L, Chen X, et al. Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling. Blood. 2008;112:4694–4698.
   PubMed Web of Science ®Google Scholar
• Wallenstein GV, Kanik KS, Wilkinson B, et al. Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials. Clin Exp Rheumatol. 2016 May-Jun;34(3):430–442.
   PubMed Web of Science ®Google Scholar
• Bilori B, Thota S, Clemente MJ, et al. Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia. Leukemia. 2015 Dec;29(12):2427–2429.
   PubMed Web of Science ®Google Scholar
• Marchand T, Lamy T, Finel H, et al. Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation. Leukemia. 2016 May;30(5):1201–1204.
   PubMed Web of Science ®Google Scholar